▁British 10.375
▁Bi 10.8671875
ote 5.58984375
ch 4.453125
▁Pl 7.578125
c 5.9140625
' 6.21875
s 0.485595703125
▁Can 6.015625
cer 1.32421875
▁D 3.619140625
rug 4.30078125
▁Mar 9.4453125
im 7.8125
ast 10.4921875
at 7.90625
▁Sh 7.1484375
ows 4.9453125
▁Promise 10.71875
, 7.796875
▁But 6.26171875
▁F 6.05078125
aces 4.2734375
▁H 5.875
urd 4.16015625
les 1.025390625
▁to 6.8359375
▁Be 5.2265625
come 2.22265625
▁a 2.9609375
▁Block 8.0078125
b 2.466796875
uster 0.2744140625
<0x0A> 4.99609375
<0x0A> 4.85546875
B 4.21875
rit 4.64453125
ish 0.128662109375
▁Bi 5.25
ote 0.14306640625
ch 0.23681640625
▁P 5.1484375
LC 0.38134765625
▁today 11.484375
▁announced 6.40234375
▁positive 6.96875
▁results 0.86572265625
▁from 0.65869140625
▁a 1.1630859375
▁late 3.970703125
- 0.162109375
stage 0.06268310546875
▁clin 1.115234375
ical 0.0007605552673339844
▁trial 0.29248046875
▁of 0.775390625
▁its 0.72509765625
▁experimental 3.3828125
▁cancer 2.09765625
▁drug 0.6328125
▁Mar 7.48828125
im 3.22265625
ast 0.022613525390625
at 0.0017938613891601562
. 0.892578125
▁The 1.2412109375
▁drug 0.85986328125
▁uses 6.3671875
▁a 0.9130859375
▁novel 2.84375
▁approach 1.958984375
▁to 0.32568359375
▁blocking 4.6640625
▁tum 3.431640625
or 0.2117919921875
▁growth 0.6279296875
▁by 1.1689453125
▁in 2.64453125
hib 0.01343536376953125
iting 0.0062103271484375
▁en 4.859375
zym 0.003261566162109375
es 0.051361083984375
▁that 0.95458984375
▁allow 4.95703125
▁cancer 0.7548828125
▁cells 0.08935546875
▁to 0.016387939453125
▁in 7.61328125
va 0.0931396484375
de 3.0159950256347656e-05
▁surrounding 2.75390625
▁t 0.4716796875
issues 0.8798828125
. 0.460205078125
▁ 5.1328125
<0x0A> 1.19921875
<0x0A> 0.15185546875
In 3.154296875
▁a 1.9140625
▁Ph 2.380859375
ase 0.0008955001831054688
▁ 0.521484375
3 0.703125
▁trial 0.93994140625
▁of 1.1591796875
▁ 0.93701171875
3 1.98046875
4 2.49609375
7 2.80859375
▁patients 0.255859375
▁with 0.449462890625
▁advanced 1.064453125
▁pan 2.673828125
cre 0.0006909370422363281
atic 0.01552581787109375
▁cancer 0.11822509765625
, 0.213134765625
▁Mar 1.119140625
im 0.0018444061279296875
ast 0.006618499755859375
at 0.0007863044738769531
▁increased 4.71875
▁median 2.306640625
▁surv 1.2841796875
ival 0.0017833709716796875
▁time 2.109375
▁from 2.087890625
▁ 0.319580078125
4 2.990234375
. 0.272216796875
2 2.408203125
▁months 0.33837890625
▁to 0.313232421875
▁ 0.05450439453125
5 2.59765625
. 0.021392822265625
8 1.96875
▁months 0.02203369140625
, 1.19921875
▁a 1.8427734375
▁ 0.7275390625
3 1.2939453125
8 2.6328125
% 1.044921875
▁improvement 0.92138671875
▁compared 3.826171875
▁to 0.271728515625
▁standard 2.0390625
▁chem 1.1943359375
other 0.018585205078125
apy 0.0248565673828125
▁alone 3.498046875
. 0.172119140625
▁Pat 3.923828125
ients 0.029266357421875
▁receiving 1.869140625
▁the 1.333984375
▁drug 1.2158203125
▁also 1.8515625
▁reported 3.265625
▁improved 2.896484375
▁quality 0.52783203125
▁of 0.0274200439453125
▁life 0.0025482177734375
▁and 1.517578125
▁fewer 2.16796875
▁side 0.342041015625
▁effects 0.021087646484375
▁compared 1.8173828125
▁to 0.08758544921875
▁chem 2.208984375
other 0.0284576416015625
apy 0.0035037994384765625
. 2.162109375
<0x0A> 0.96044921875
<0x0A> 0.034210205078125
" 3.556640625
Th 2.58984375
ese 0.0306396484375
▁results 0.89794921875
▁show 3.359375
▁the 1.595703125
▁potential 0.89111328125
▁for 1.548828125
▁Mar 0.419189453125
im 0.0011224746704101562
ast 0.006359100341796875
at 0.0003788471221923828
▁to 0.431884765625
▁become 2.80078125
▁an 1.734375
▁important 0.34228515625
▁new 0.720703125
▁treatment 0.5673828125
▁option 0.56640625
▁for 0.153076171875
▁patients 0.4560546875
▁with 0.1767578125
▁this 3.2265625
▁dev 1.9482421875
ast 9.655952453613281e-05
ating 0.00018107891082763672
▁disease 0.445068359375
," 0.281005859375
▁said 0.273681640625
▁Dr 1.6552734375
. 0.1865234375
▁Jane 6.45703125
▁Smith 5.65625
, 0.099853515625
▁British 3.56640625
▁Bi 0.00841522216796875
ote 0.0002932548522949219
ch 0.01439666748046875
' 0.41552734375
s 0.0023860931396484375
▁Chief 0.953125
▁Medical 0.55712890625
▁Officer 0.034393310546875
, 2.958984375
▁in 1.2080078125
▁a 0.2310791015625
▁statement 1.2607421875
. 0.11907958984375
▁The 4.56640625
▁company 1.123046875
▁plans 2.134765625
▁to 0.05889892578125
▁seek 2.2890625
▁regul 1.404296875
atory 0.00020420551300048828
▁appro 0.0506591796875
val 5.996227264404297e-05
▁for 0.65771484375
▁the 0.70068359375
▁drug 0.2181396484375
▁in 0.58837890625
▁the 0.7822265625
▁UK 4.39453125
▁and 0.794921875
▁EU 2.873046875
▁based 6.30078125
▁on 0.0224456787109375
▁these 0.908203125
▁results 0.56396484375
. 0.249755859375
<0x0A> 0.27880859375
<0x0A> 0.0184783935546875
However 6.1640625
, 0.03546142578125
▁industry 8.015625
▁anal 1.3896484375
yst 0.00043892860412597656
s 0.07891845703125
▁ca 3.529296875
ution 0.0016193389892578125
ed 0.578125
▁that 0.191162109375
▁Mar 3.060546875
im 0.0021533966064453125
ast 0.00556182861328125
at 0.0012722015380859375
▁still 3.193359375
▁faces 1.2490234375
▁significant 1.9072265625
▁hur 0.515625
d 9.298324584960938e-06
les 0.0001881122589111328
▁to 1.14453125
▁become 2.583984375
▁a 0.138916015625
▁commercial 1.525390625
▁block 4.42578125
b 0.0011882781982421875
uster 0.00034546852111816406
. 0.82421875
▁As 5.1484375
▁an 4.453125
▁adj 5.859375
unct 0.419921875
ive 2.943359375
▁treatment 1.5126953125
, 0.853515625
▁it 2.255859375
▁would 2.041015625
▁need 1.65234375
▁to 0.176025390625
▁be 0.5849609375
▁used 2.759765625
▁in 0.6484375
▁combination 0.80615234375
▁with 0.00606536865234375
▁chem 1.6171875
other 0.01153564453125
apy 0.01357269287109375
, 1.541015625
▁limit 6.703125
ing 0.02734375
▁its 0.337158203125
▁potential 1.6181640625
▁as 2.578125
▁a 0.1185302734375
▁stand 1.494140625
- 0.72607421875
alone 0.002017974853515625
▁drug 1.2451171875
. 0.1370849609375
▁The 2.169921875
▁surv 7.97265625
ival 0.0023784637451171875
▁benefit 1.369140625
, 4.515625
▁while 1.7265625
▁statist 2.892578125
ically 1.823902130126953e-05
▁significant 0.0740966796875
, 0.0660400390625
▁is 1.3291015625
▁still 3.533203125
▁relatively 3.06640625
▁mod 0.75439453125
est 3.123283386230469e-05
. 1.486328125
▁And 1.927734375
▁with 4.734375
▁many 4.56640625
▁new 3.865234375
▁cancer 0.96533203125
▁dru 0.380859375
gs 2.86102294921875e-06
▁coming 3.806640625
▁to 0.289306640625
▁market 0.14208984375
, 1.0693359375
▁the 1.990234375
▁competition 3.822265625
▁will 2.67578125
▁be 0.7001953125
▁inten 1.900390625
se 2.849102020263672e-05
. 0.318603515625
<0x0A> 0.390380859375
<0x0A> 0.0217437744140625
The 3.080078125
▁biggest 5.7421875
▁challenge 1.462890625
, 1.861328125
▁though 2.58984375
, 0.00421905517578125
▁may 1.384765625
▁be 0.1826171875
▁the 1.7353515625
▁complexity 6.58203125
▁and 2.8359375
▁cost 0.97021484375
▁of 0.09051513671875
▁the 1.68359375
▁large 7.0703125
▁clin 1.2470703125
ical 0.001125335693359375
▁tri 1.2578125
als 9.632110595703125e-05
▁needed 0.94921875
▁to 0.09783935546875
▁test 3.451171875
▁Mar 1.3486328125
im 0.0006952285766601562
ast 0.00560760498046875
at 0.001117706298828125
▁in 2.05859375
▁other 3.1328125
▁types 2.021484375
▁of 0.0044097900390625
▁solid 3.259765625
▁tum 0.1173095703125
ors 0.145751953125
, 1.673828125
▁like 4.06640625
▁breast 0.857421875
, 1.5537109375
▁colon 2.466796875
, 0.31298828125
▁and 0.3955078125
▁lung 0.97216796875
▁can 1.0751953125
cers 4.482269287109375e-05
. 0.1834716796875
▁Th 8.3671875
ous 0.305419921875
ands 0.0011129379272460938
▁of 0.023101806640625
▁patients 0.1983642578125
▁would 1.05078125
▁need 0.396240234375
▁to 0.017242431640625
▁be 0.2178955078125
▁en 0.52587890625
rolled 0.000812530517578125
▁in 0.546875
▁random 5.828125
ized 0.0135498046875
▁tri 0.63818359375
als 3.5762786865234375e-06
▁across 3.646484375
▁many 2.70703125
▁countries 2.62109375
, 1.2919921875
▁at 4.41796875
▁a 1.34375
▁potential 6.578125
▁cost 0.1405029296875
▁of 0.13671875
▁over 3.43359375
▁$ 0.12066650390625
1 0.66015625
0 1.7724609375
0 0.1912841796875
▁million 0.12109375
▁per 1.4345703125
▁trial 1.3017578125
. 0.205322265625
<0x0A> 0.64990234375
<0x0A> 0.0181121826171875
B 2.767578125
rit 0.02117919921875
ish 0.0018320083618164062
▁Bi 0.004825592041015625
ote 4.673004150390625e-05
ch 0.0052490234375
▁has 2.994140625
▁just 5.9921875
▁$ 3.326171875
4 2.412109375
2 2.619140625
▁million 0.297607421875
▁in 0.146484375
▁c 0.285400390625
ash 0.00016391277313232422
▁res 3.34765625
erves 0.00016760826110839844
▁after 4.07421875
▁heavy 9.78125
▁sp 1.1953125
ending 0.000476837158203125
▁on 0.445556640625
▁the 1.8017578125
▁pan 4.3046875
cre 0.001811981201171875
atic 0.0202484130859375
▁cancer 0.09814453125
▁tri 3.09375
als 1.6570091247558594e-05
. 0.7431640625
▁The 1.4794921875
▁company 0.134521484375
▁will 3.009765625
▁need 0.865234375
▁to 0.34765625
▁for 8.59375
ge 0.32861328125
▁partners 1.39453125
hips 0.0102996826171875
▁with 1.3359375
▁larger 2.314453125
▁ph 0.423583984375
arma 0.0066375732421875
ce 0.036041259765625
ut 8.702278137207031e-06
ical 3.075599670410156e-05
▁fir 2.3828125
ms 1.7881393432617188e-06
▁to 0.6533203125
▁fin 2.05078125
ance 0.00025200843811035156
▁additional 3.255859375
▁studies 2.998046875
, 1.8642578125
▁but 3.345703125
▁may 4.015625
▁have 2.12890625
▁to 0.62548828125
▁sacrifice 3.833984375
▁a 3.43359375
▁considerable 7.29296875
▁share 2.36328125
▁of 0.0841064453125
▁future 2.9609375
▁prof 0.64599609375
its 6.818771362304688e-05
▁in 1.3642578125
▁the 0.638671875
▁process 0.135009765625
. 0.057891845703125
<0x0A> 0.237548828125
<0x0A> 0.042327880859375
Some 6.31640625
▁anal 1.3076171875
yst 0.0001481771469116211
s 0.0012464523315429688
▁argue 4.4375
▁that 0.1578369140625
▁Mar 2.48046875
im 0.0009889602661132812
ast 0.00434112548828125
at 0.0006465911865234375
▁could 1.9228515625
▁still 2.603515625
▁find 4.07421875
▁a 0.51025390625
▁n 2.09375
iche 2.1457672119140625e-05
, 3.833984375
▁especially 3.2265625
▁if 1.9384765625
▁proven 7.3984375
▁effective 1.185546875
▁for 2.662109375
▁patients 2.62109375
▁with 0.26806640625
▁certain 3.6171875
▁bi 7.6953125
om 0.175537109375
ark 0.0010938644409179688
ers 0.2457275390625
▁or 2.337890625
▁in 2.95703125
▁combination 1.9404296875
▁with 0.06378173828125
▁other 0.59521484375
▁dru 0.73681640625
gs 3.0994415283203125e-05
. 0.1719970703125
▁The 2.861328125
▁most 4.7734375
▁likely 1.833984375
▁partners 5.375
▁would 1.6982421875
▁be 0.10528564453125
▁major 4.484375
▁on 2.158203125
col 0.209228515625
ogy 3.695487976074219e-05
▁players 2.287109375
▁like 0.8427734375
▁A 2.4140625
stra 0.10028076171875
Z 0.05792236328125
en 0.0006117820739746094
eca 0.0022525787353515625
, 1.052734375
▁Gla 4.44921875
x 0.0008592605590820312
o 0.002094268798828125
Smith 0.044952392578125
K 0.0032978057861328125
line 0.005138397216796875
, 0.056854248046875
▁and 0.89697265625
▁Mer 1.890625
ck 0.000934600830078125
. 1.19140625
<0x0A> 0.81982421875
<0x0A> 0.0172576904296875
For 4.47265625
▁now 0.82275390625
, 0.03167724609375
▁British 0.91748046875
▁Bi 0.0023956298828125
ote 2.300739288330078e-05
ch 0.0016279220581054688
▁has 2.4921875
▁cleared 7.875
▁an 2.91796875
▁important 0.08453369140625
▁hur 0.50341796875
d 7.3909759521484375e-06
le 9.202957153320312e-05
, 1.6171875
▁but 1.2255859375
▁the 1.71484375
▁road 1.841796875
▁ahead 0.266357421875
▁remains 1.7138671875
▁long 0.97802734375
. 1.3466796875
▁With 5.46875
▁science 9.4921875
▁on 4.01953125
▁their 2.50390625
▁side 0.00244140625
▁but 7.0546875
▁money 2.943359375
▁in 3.125
▁short 0.8134765625
▁supply 0.0012102127075195312
, 0.0214996337890625
▁the 1.130859375
▁company 0.350341796875
▁will 1.453125
▁have 1.15234375
▁to 0.08013916015625
▁run 7.23046875
▁a 1.9736328125
▁ga 4.95703125
unt 0.00018966197967529297
let 0.0007100105285644531
▁of 0.2105712890625
▁financial 3.966796875
, 2.015625
▁clin 2.92578125
ical 0.0007605552673339844
, 0.04241943359375
▁and 0.1790771484375
▁commercial 4.06640625
▁challeng 1.404296875
es 0.00010991096496582031
▁to 0.82275390625
▁turn 3.44140625
▁their 3.763671875
▁prom 2.16796875
ising 5.614757537841797e-05
▁new 2.27734375
▁drug 0.325439453125
▁into 0.0307464599609375
▁a 0.1259765625
▁sust 4.62890625
ain 0.0472412109375
able 0.003734588623046875
▁business 1.2734375
. 0.142578125
▁Pat 9.7578125
ients 0.2108154296875
▁and 1.9736328125
▁invest 2.205078125
ors 0.0005741119384765625
▁al 1.6640625
ike 2.09808349609375e-05
▁will 0.6494140625
▁be 0.767578125
▁following 6.09765625
▁closely 1.0439453125
▁to 1.7529296875
▁see 0.07098388671875
▁if 0.8701171875
▁Mar 2.296875
im 0.0005254745483398438
ast 0.004261016845703125
at 0.0001976490020751953
▁can 0.88818359375
▁stay 6.55078125
▁the 1.2548828125
▁course 0.0163116455078125
. 0.252685546875
